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Fig 2. Freedom from stroke/myocardial infarction/death.
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P < .038).
Conclusions: Compared with prestent ballooning alone, the use of
poststent deployment ballooning increases the chances of perioperative he-
modynamic instability and stroke/death rate in patients undergoing carotid
artery stenting. Poststent ballooning should be limited to select populations
only.
Author Disclosures: M. Malas: None; T. Obeid: None; I. Arhuidese:
None; U. Qazi: None; C. Abularrage: None; J. Black: None; B. Perler:
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Introduction: Several studies have reported on the role of postoper-
ative duplex ultrasound surveillance after carotid endarterectomy (CEA),
with varying results. Most of these studies had a small sample size and/or
did not analyze cost-effectiveness. Therefore, there is no consensus
regarding its usefulness and whether it is cost-effective.
Methods: Analyzedwere489of501CEApatientswithpatchclosure.All
patients had immediate postoperative duplex ultrasound imaging and were
routinely followed up clinically and with duplex ultrasound imaging at regular
intervals of 1, 6, and 12 months, and every 12 months thereafter. A Kaplan-
Meier analysiswas used to estimate the rate of$50% and$80%post-CEA reste-
nosis over time and the time frame of progression from normal to $50% or
$80% restenosis. The cost of post-CEA duplex surveillance was also estimated.
Results: Overall, 489 patients (mean age, 68.5 years) were analyzed.
Ten of these had residual postoperative $50% stenosis, and 37 did not un-
dergo a second duplex ultrasound assessment and, therefore, were not
included in the ﬁnal analysis. The mean follow-up was 20.4 months (range,
1-63 months), with a mean number of duplex ultrasound assessments of 3.6
(range, 1-7). Eleven of 397 patients (2.8%) with a normal immediate post-
operative duplex ultrasound assessment vs four of 45 (8.9%) with mild ste-
nosis on immediate postoperative duplex ultrasound imaging progressed to
$50% restenosis (P ¼ .055). Overall, 15 patients (3.1%) had $50% resteno-
sis: nine with 50% to <80%, four with 80% to 99% (two of these had carotid
artery stenting reintervention), and two had late carotid occlusion. All of
these were asymptomatic, except for one who had a transient ischemic
attack. The mean time to $50% to <80% restenosis was 14.7 months vs
19.8 months for $80% restenosis after the CEA. Freedom from $50%
and $80% restenosis rates were 98%, 96%, 94%, 94%, 94%, and 99%,
98%, 97%, 97%, and 97% at 1, 2, 3, 4, and 5 years, respectively (Fig 1).
Freedom from myocardial infarction, stroke, or death was not signiﬁcantly
different between patients with and without restenosis (100%, 93%, 83%,Fig 1. Freedom from >50 and >80 restenosis.and 83% vs 94%, 91%, 86%, and 79% at 1, 2, 3, and 4 years, respectively;
P ¼ .951; Fig 2). The estimated cost of this surveillance was 3.6  489
(number of CEAs)  $800 (charge for carotid duplex ultrasound), which
is $1,408,320 to detect only four patients with $80% to 99% restenosis
who might have been potential candidates for reintervention.
Conclusions: This study conﬁrms that routine postoperative duplex
ultrasound surveillance after CEA with patch closure is not necessary or
cost-effective, particularly if the immediate postoperative duplex ultrasound
assessment was normal or showed minimal disease.
Author Disclosures: A. F. AbuRahma: None; M. Srivastava: None; Z.
AbuRahma: None; W. Jackson: None; P. A. Stone: None; J. Green:
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Introduction: Although numerous studies have described the inci-
dence of postoperative cranial nerve injury (CNI) after carotid endarterec-
tomy (CEA), there have been very few attempts to identify risk factors for
this complication.
Methods: The 2012 CEA-targeted American College of Surgeons
National Surgical Quality Improvement Program (ASC-NSQIP) database
was used to determine the incidence of CNI after CEA. A patient was noted
to have a postoperative CNI if his or her in-hospital or postdischarge (up to
30 days) medical record contained mention of such an injury or of symp-
toms consistent with such an injury. Thus, those CNIs captured by this
database are likely to represent clinically relevant injuries. Multivariate logis-
tic regression analysis was performed to identify independent predictors of
CNI after CEA, using a comprehensive array of patient-, disease-, and pro-
cedure-related factors (including prior ipsilateral carotid surgery and other
high-risk anatomic risk factors) as potential predictor variables.
Results: Of the 4013 patients who underwent CEA and were
included in our analysis, 87 (2.2%) were noted to have sustained CNI in
the ﬁrst 30 postoperative days. Independent predictors of this complication
included age $80 years (reference group <70 years; adjusted odds ratio
[AOR] for CNI, 1.74; 95% conﬁdence interval [CI], 1.00-3.03; P ¼
.05), preoperative bleeding disorder, including patients in whom preopera-
tive anticoagulation was not stopped or reversed (AOR, 1.66; 95% CI, 1.03-
2.68; P ¼ .04), duration of operation (AOR for each 30 minutes beyond an
operative time of 90 minutes, 1.15; 95% CI, 1.06-1.25; P ¼ .001), and need
for reoperation (AOR, 2.65; 95% CI, 1.03-6.80; P ¼ .04).
Conclusions: Our study demonstrates clinically evident CNI is a rela-
tively uncommon event after CEA at institutions that participate in the
CEA-targeted ACS-NSQIP program. Anatomic high-risk factors, including
prior neck irradiation or ipsilateral carotid surgery, were not signiﬁcantly
associated with an increased incidence of CNI in our study, although
Fig. Rates of myocardial infarction (MI) by treatment with antiplatelet and
statin medications across cardiac risk. ASA, Acetylsalicylic acid.
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 6 Abstracts 1721such factors are typically cited as relative contraindications to CEA instead of
carotid stenting. The ﬁndings of our study do suggest that patients who
require prolonged operation for hemostasis or other reasons may beneﬁt
if possible from intermittent release of intraoperative retraction in order to
prevent temporary cranial nerve palsy and that surgeons should exercise
particular caution in patients who require early reoperation after CEA.
Author Disclosures: K. M. Bennett: None; J. E. Scarborough: None; C.
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Surgeon Radiation Dose During Complex Endovascular Procedures
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Introduction: Surgeon radiation dose during complex endovascular
procedures (CEPs) has not been well studied. We sought to characterize ra-
diation exposure to surgeons during CEPs based on procedure type, oper-
ator position, level of operator training, upper vs lower body exposure, and
the addition of protective shielding.
Methods: Optically stimulable, luminescent nanoDot (Landauer Inc)
detectors were used tomeasure radiation dose prospectively to surgeons during
CEPs. NanoDot dosimeters were placed outside the lead apron of the primary
and assistant operator at the left upper chest and left lower pelvis positions. For
each case, procedure type, reference air kerma (RAK), kerma area product
(KAP), the relative position of the operator, level of training of the fellow,
and presence or absence of external additional shielding devices were recorded.
Threepositionswere assignedon the right hand side of the patient in decreasing
relative proximity to the ﬂat panel detector (FPD) as A, B, and C, respectively.
Position A (main operator) was closest to the FPD. Position D was on the left
side of thepatient at thebrachial access site.NanoDotswere readusingaMicro-
star II medical dosimetry system (Landauer Inc) after every procedure. The
nanoDot dosimetry systemwas calibrated for scattered radiation in an endovas-
cular suite with a NIST-traceable solid state radiation detector (Piranha T20,
RTI). Comparative statistical analyses of nanoDot dose levels between cate-
gories was performed using analysis of variance with Tukey pairwise compari-
sons. Bonferroni correction was used for multiple comparisons.
Results: There were 415 nanoDot measurements with the following
case distribution: 16 thoracic endovascular aortic repairs or endovascular
aneurysm repairs, 18 fenestrated endovascular aneurysm repairs (FEVARs),
13 embolizations, 41 lower extremity, 10 ﬁstulograms, and 13 viscerals. The
mean operator dose for FEVARs was statistically higher than for other case
types (P < .03), 15 mSv at position A and 11 mSv at position B. For all case
types, positions A (8.7 6 2.7 mSv) and D (14.4 6 7.8 mSv) received statis-
tically higher effective doses than B (3.9 6 2.7 mSv; P < .001 or C (0 mGy).
However, the mean operator dose for position D was not statistically
different from position A. The addition of the lead skirt signiﬁcantly
decreased the lower body dose (33 6 3.4 mSv to 6.3 6 3.3 mSv) but not
the upper body dose (6.5 6 3.3 mSv to 5.7 6 2.2 mSv). The use of ceil-
ing-mounted shielding did not affect the nanoDot dose. There was no dif-
ference in the operator dose observed based on level of training when the
fellow was in position A. KAP was the better predictor of operator radiation
dose compared with RAK. The mean KAP for all cases was 330 Gycm2, and
the regression coefﬁcient for operator dose to KAP was 0.021 6
0.003 mSv/Gycm2 for position A and 0.015 6 0.003 mSv/Gycm2 for B.
Conclusions: Surgeon radiation dose during CEPs depends on case
type, operator position, and table skirt use, but not on the level of fellow
training. On the basis of this data, the primary operator could performw12
FEVARs per week and have an annual dose of <10 mSv, which would not
exceed lifetime occupational dose limits during a 35-year career. Excluding
FEVARs with the above case mix, the primary operator could performw40
CEPs per week and stay within regulatory limits. With practical case loads,
operator doses are relatively low and unlikely to exceed occupational limits.
Author Disclosures:M. L. Kirkwood:None; J. Guild:None;G.Arbique:
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Introduction: Medical management (MM) with antiplatelet (AP)
and statin therapy is recommended for most patients undergoing vascularsurgery. We evaluated the preoperative use of these on postoperative
myocardial infarction (MI) in patients undergoing high-risk procedures
within the Vascular Quality Initiative (VQI).
Methods: We studied VQI patients undergoing elective suprainguinal
(n ¼ 3039) and infrainguinal bypass (n ¼ 8323) and open abdominal aortic
aneurysm repair (n ¼ 3007) from 2005 to 2014. We examined the use of
MM (AP or statin, or both) on postoperative MI and postoperative death.
Multivariable analyses were performed to identify factors associated with
preoperative MM use as well as and MI and MI/death rates across proce-
dures and cardiac risk strata (using Vascular Study Group of New England
cardiac risk criteria).
Results: Overall, most patients were on both AP and statin at the time
of surgery (56% vs 12% neither agent, 19% AP only, 17% statin only), and
MM was similar across procedure groups. Rates of MI were similar despite
MM strategy, with slightly higher rates in patients on both agents (neither
AP or statin, 2.4%; AP only, 2.6%; statin only, 2.8%; both, 3.7%; P ¼ .003).
MI increased with cardiac risk (1.8% vs 3.8% vs 6.5% for low, medium, and
high risk; P < .01). When MI was stratiﬁed by cardiac risk, MM did not
reduce MI rates and was slightly higher for patients on both agents (Fig).
After multivariable adjustment for MI, MM was not associated with reduced
MI compared with those on neither medication (AP only: odds ratio [OR],
1.0; 95% conﬁdence interval [CI], 0.6-1.5; statin only: OR, 0.9; 95% CI,
0.5-1.4; both agents, OR, 1.0; 95% CI, 0.7-1.5; P > .05 for all). Findings
were similar for combined outcome of MI/death. Finally, analysis demon-
strated that APs and statins were used more often in patients with known
cardiovascular risk factors.
Conclusions: These data conﬁrm that MI events are highly associated
with a patient’s estimated cardiac risk. However, lack of MM did not result
in higher rates of MI. It appears that higher-risk patients are currently
selected for MM in VQI but that this is not associated with reduced post-
operative MI or MI-related mortality.Author Disclosures: R. R. DeMartino: None; A. W. Hoel: None; A. W.
Beck: None; J. W. Hallett: None; S. Arya: None; G.H. Upchurch: None;
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Gainesville, Gainesville, Fla; 2University of Florida-Gainesville, Gainesville,
Fla; 3University of Vermont-Burlington, Burlington, Vt; 4Maine Medical
Center, Portland, Me; 5Dartmouth-Hitchcock Medical Center, Lebanon,
NH
Introduction: Arrival heart rate (AHR) and heart rate control (HRC)
are known indicators of cardiovascular complications after cardiac surgery, but
there is little evidence of their role in predicting outcome after major vascular
surgery. The purpose of this study was to determine whether AHR and HRC
are predictive of mortality or major adverse cardiac events (MACE) after elec-
tive vascular surgery in the Vascular Quality Initiative (VQI).
Methods: The VQI data set was used to perform a retrospective anal-
ysis of patients undergoing elective infrainguinal bypass (IIB), suprainguinal
bypass (SIB), and open abdominal aortic aneurysm (AAA) repair (oAAA).
MACE was deﬁned as any postoperative myocardial infarction (POMI),
dysrhythmia, or congestive heart failure. Controlled HR was deﬁned as a
HR of <75 beats/min upon operating room arrival. HRC was determined
by taking the highest intraoperative HR-AHR. Procedure-speciﬁc MACE
